GILEAD SCIENCES, INC. GILD 57.29
Health Care · NASDAQ · Data as of 2026-10-30
GILEAD SCIENCES, INC. (GILD) has delivered +1.3% annualized revenue growth, -9.5% earnings growth, and +5.4% dividend growth over 10 years of data. Ranked #622 of 1968 stocks overall and #54 of 260 in the Health Care sector by Steady Score.
Industry
Biological Products
Steady Score
57.29
Overall Rank
#622 / 1968
Sector Rank
#54 / 260
Revenue CAGR
+1.3%
Earnings CAGR
-9.5%
Dividend CAGR
+5.4%
?
E/R CAGR Ratio
-7.4x
Revenue
Earnings
Dividends
Free Cash Flow
Margin
NET Margin
FCF Margin
Payout Ratio
Payout Ratio
FCF Payout Ratio